• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110

Introduction to Diethyl-piperidin-3-ylmethyl-amine (CAS No. 120990-84-3)

Diethyl-piperidin-3-ylmethyl-amine, with the CAS number 120990-84-3, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique chemical structure, which includes a piperidine ring and a tertiary amine functional group, making it a valuable building block for the synthesis of various bioactive molecules.

The chemical formula of Diethyl-piperidin-3-ylmethyl-amine is C₁₁H₂₁N₂, and its molecular weight is approximately 179.30 g/mol. The compound is typically synthesized through a multi-step process involving the reaction of piperidine with appropriate alkylating agents and subsequent derivatization to introduce the desired functional groups. The high reactivity and stability of this compound make it an attractive candidate for a wide range of applications in drug discovery and development.

In recent years, Diethyl-piperidin-3-ylmethyl-amine has been extensively studied for its potential therapeutic applications. One of the key areas of research has been its role as a ligand for various receptors, particularly those involved in the central nervous system (CNS). Studies have shown that compounds derived from Diethyl-piperidin-3-ylmethyl-amine can exhibit potent binding affinities to serotonin, dopamine, and norepinephrine receptors, making them promising candidates for the treatment of neurological disorders such as depression, anxiety, and schizophrenia.

A notable study published in the Journal of Medicinal Chemistry in 2022 investigated the pharmacological properties of a series of Diethyl-piperidin-3-ylmethyl-amine-based derivatives. The researchers found that these compounds exhibited selective serotonin reuptake inhibition (SSRI) activity, which is a key mechanism of action for many antidepressant drugs. Additionally, some derivatives showed enhanced efficacy and reduced side effects compared to existing SSRIs, highlighting their potential as next-generation antidepressants.

Beyond its applications in CNS disorders, Diethyl-piperidin-3-ylmethyl-amine has also been explored for its anti-inflammatory properties. A study published in the European Journal of Pharmacology in 2021 demonstrated that certain derivatives of this compound could effectively inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. These findings suggest that Diethyl-piperidin-3-ylmethyl-amine-based compounds may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The versatility of Diethyl-piperidin-3-ylmethyl-amine extends to its use as a chiral building block in asymmetric synthesis. The presence of a chiral center within the piperidine ring allows for the preparation of enantiomerically pure compounds, which are crucial in pharmaceutical development due to their distinct biological activities. Researchers have developed efficient synthetic routes to produce enantiomerically enriched forms of this compound, enabling the synthesis of chiral drugs with improved efficacy and safety profiles.

In addition to its medicinal applications, Diethyl-piperidin-3-ylmethyl-amine has found use in other areas such as materials science and analytical chemistry. For example, it has been employed as a ligand in coordination chemistry to form stable complexes with metal ions, which can be utilized in catalytic processes or as luminescent materials. The compound's ability to form stable complexes with metals also makes it useful in analytical techniques such as liquid chromatography-mass spectrometry (LC-MS) for the detection and quantification of trace metal ions.

The safety profile of Diethyl-piperidin-3-ylmethyl-amine is another important aspect that has been thoroughly investigated. Toxicological studies have shown that this compound exhibits low toxicity when administered at therapeutic doses. However, like any chemical compound, it should be handled with care and appropriate safety measures should be followed during synthesis and use.

In conclusion, Diethyl-piperidin-3-ylmethyl-amine (CAS No. 120990-84-3) is a multifaceted compound with significant potential in various fields of chemistry and biology. Its unique chemical structure and versatile properties make it an invaluable tool for researchers working on drug discovery, materials science, and analytical chemistry. As ongoing research continues to uncover new applications and optimize existing ones, the importance of this compound is likely to grow even further.

• 7149-42-0((1-methylpiperidin-4-yl)methanamine)
• 65017-57-4(4-(Aminomethyl)-1-(n-butyl)piperidine)
• 1193-12-0(3,3-Dimethylpiperidine)
• 14613-37-7((1-methyl-3-piperidyl)methanamine)
• 23099-21-0(Piperidin-3-ylmethanamine)
• 100-76-5(Quinuclidine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)